𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response

✍ Scribed by Yasuharu Imai; Akinori Kasahara; Hideo Tanaka; Takeshi Okanoue; Naoki Hiramatsu; Hirohito Tsubouchi; Kentaro Yoshioka; Sumio Kawata; Eiji Tanaka; Keisuke Hino; Katsuhiro Hayashi; Shinji Tamura; Yoshito Itoh; Yutaka Sasaki; Kendo Kiyosawa; Shinichi Kakumu; Kiwamu Okita; Norio Hayashi

Publisher
Springer Japan
Year
2004
Tongue
English
Weight
208 KB
Volume
39
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prolonged-interferon therapy reduces hep
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C
✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

## Abstract The aim of this study was to elucidate the reduction of hepatocarcinogenesis by prolonged interferon (IFN) monotherapy in aged chronic hepatitis C patients. Inclusion criteria were biopsy‐proven chronic hepatitis or liver cirrhosis, 60 years and over, elevated serum aminotransferase and

Hepatitis C virus genome complexity corr
Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C
✍ B Le Guen; G Squadrito; B Nalpas; P Berthelot; S Pol; C Brechot πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 2 views

Recent studies performed in Japan have suggested that hepatitis C virus (HCV) genome heterogeneity might be taken as a predictive virological parameter of response to interferon alfa (IFN-alpha) treatment. However, there is presently no information on the impact of this virological parameter in pati